NCT05500092
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05500092
Title An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer (CA209-6K6)
Acronym CA209-6K6
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Montefiore Medical Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Washington University in St. Louis St Louis Missouri 63130 United States Details
Montefiore Medical Center-Albert Einstein College of Medicine The Bronx New York 10461 United States Details
White Plains Hospital (WPH) White Plains New York 10601 United States Details
Penn State Health Milton S. Hershey Medical Center Hershey Pennsylvania 17033 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field